Charles Schwab’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-117,692
| Closed | -$608K | – | 3240 |
|
|
2019
Q2 | $608K | Buy |
117,692
+26,532
| +29% | +$137K | ﹤0.01% | 2732 |
|
|
2019
Q1 | $329K | Sell |
91,160
-22,610
| -20% | -$81.6K | ﹤0.01% | 2916 |
|
|
2018
Q4 | $698K | Buy |
113,770
+18,460
| +19% | +$113K | ﹤0.01% | 2650 |
|
|
2018
Q3 | $557K | Buy |
95,310
+5,210
| +6% | +$30.4K | ﹤0.01% | 2798 |
|
|
2018
Q2 | $383K | Hold |
90,100
| – | – | ﹤0.01% | 2881 |
|
|
2018
Q1 | $398K | Buy |
90,100
+17,300
| +24% | +$76.4K | ﹤0.01% | 2791 |
|
|
2017
Q4 | $383K | Hold |
72,800
| – | – | ﹤0.01% | 2798 |
|
|
2017
Q3 | $447K | Hold |
72,800
| – | – | ﹤0.01% | 2748 |
|
|
2017
Q2 | $527K | Hold |
72,800
| – | – | ﹤0.01% | 2674 |
|
|
2017
Q1 | $386K | Hold |
72,800
| – | – | ﹤0.01% | 2735 |
|
|
2016
Q4 | $523K | Hold |
72,800
| – | – | ﹤0.01% | 2631 |
|
|
2016
Q3 | $682K | Buy |
72,800
+19,400
| +36% | +$182K | ﹤0.01% | 2514 |
|
|
2016
Q2 | $338K | Hold |
53,400
| – | – | ﹤0.01% | 2740 |
|
|
2016
Q1 | $295K | Hold |
53,400
| – | – | ﹤0.01% | 2782 |
|
|
2015
Q4 | $298K | Hold |
53,400
| – | – | ﹤0.01% | 2864 |
|
|
2015
Q3 | $452K | Sell |
53,400
-7,200
| -12% | -$60.9K | ﹤0.01% | 2662 |
|
|
2015
Q2 | $917K | Buy |
60,600
+8,500
| +16% | +$129K | ﹤0.01% | 2449 |
|
|
2015
Q1 | $835K | Buy |
52,100
+6,200
| +14% | +$99.4K | ﹤0.01% | 2445 |
|
|
2014
Q4 | $818K | Hold |
45,900
| – | – | ﹤0.01% | 2438 |
|
|
2014
Q3 | $461K | Hold |
45,900
| – | – | ﹤0.01% | 2620 |
|
|
2014
Q2 | $717K | Buy |
+45,900
| New | +$717K | ﹤0.01% | 2488 |
|